Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for 2013 (443 publications)

no pagination
Van Laere SJ, Ueno NT, Finetti P, Vermeulen P, Lucci A, Robertson FM, Marsan M, Iwamoto T, Krishnamurthy S, Masuda H, van Dam P, Woodward WA, Viens P, Cristofanilli M, Birnbaum D, Dirix L, Reuben JM, Bertucci F. Uncovering the Molecular Secrets of Inflammatory Breast Cancer Biology: An Integrated Analysis of Three Distinct Affymetrix Gene Expression Datasets. Clinical Cancer Research. 2013 Sep;19(17):4685-96.   PMCID: *
Wong YN, Egleston BL, Sachdeva K, Eghan N, Pirollo M, Stump TK, Beck JR, Armstrong K, Schwartz JS, Meropol NJ. Cancer Patients' Trade-offs Among Efficacy, Toxicity, and Out-of-Pocket Cost in the Curative and Noncurative Setting. Medical Care. 2013 Sep;51(9):838-45.   PMCID: PMC 3857689
Grivennikov SI. IL-11: a prominent pro-tumorigenic member of the IL-6 family. Cancer Cell. 2013 Aug 12;24(2):145-7.
Grivennikov SI. IL-11: A Prominent Pro-Tumorigenic Member of the IL-6 Family. Cancer cell. 2013 Aug 12;24(2):145-7.   PMCID: PMC 3855069
Prasad Kerlin M, Tokar JL. Acute gastrointestinal bleeding. Annals of internal medicine. 2013 Aug 06;159(3):ITC2-1, ITC2-2, ITC2-3, ITC2-4, ITC2-5, ITC2-6, ITC2-7, ITC2-8, ITC2-9, ITC2-10, ITC2-11, ITC2-12, ITC2-13, ITC2-14, ITC2-15; quiz ITC2-16.   PMCID: No NIH funding
Bagnyukova TV, Restifo D, Beeharry N, Gabitova L, Li T, Serebriiskii IG, Golemis EA, Astsaturov I. DUSP6 regulates drug sensitivity by modulating DNA damage response. British Journal of Cancer. 2013 Aug;109(4):1063-71.   PMCID: PMC 3749559
Bhat YM, Banerjee S, Barth BA, Chauhan SS, Gottlieb KT, Konda V, Maple JT, Murad FM, Pfau PR, Pleskow DK, Siddiqui UD, Tokar JL, Wang A, Rodriguez SA. Tissue adhesives: cyanoacrylate glue and fibrin sealant. Gastrointestinal endoscopy. 2013 Aug;78(2):209-15.   PMCID: Not NIH funded
Canter D, Egleston B, Wong YN, Smaldone MC, Simhan J, Greenberg RE, Uzzo RG, Kutikov A. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis. Urologic Oncology-Seminars and Original Investigations. 2013 Aug;31(6):866-70.
de Souza JA, Wong YN. Financial Distress in Cancer Patients. J Med Person. 2013 Aug;11(2):73-7.   PMCID: PMC3859450
Duran JM, Makarewich CA, Sharp TE, Starosta T, Zhu F, Hoffman NE, Chiba Y, Madesh M, Berretta RM, Kubo H, Houser SR. Bone-Derived Stem Cells Repair the Heart After Myocardial Infarction Through Transdifferentiation and Paracrine Signaling Mechanisms. Circulation research. 2013 Aug;113(5):539-52.   PMCID: PMC 3822430
Eberhardt SC, Johnson JA, Parsons RB. Oncology imaging in the abdomen and pelvis: where cancer hides. Abdominal Imaging. 2013 Aug;38(4):647-71.   PMCID: No NIH funds
Fourkal E, Veltchev I, Lin M, Koren S, Meyer J, Doss M, Yu JQ. 3D inpatient dose reconstruction from the PET-CT imaging of (90)Y microspheres for metastatic cancer to the liver: Feasibility study. Med Phys. 2013 Aug;40(8):081702.
Gabriel KP, Klifa C, Perez A, Kriska AM, High RR, Snetselaar L, Dorgan JF. Adolescent and Young Adult Exposure to Physical Activity and Breast Density. Medicine and Science in Sports and Exercise. 2013 Aug;45(8):1515-23.   PMCID: PMC 3897238
Gobbi G, Mirandola P, Carubbi C, Masselli E, Sykes SM, Ferraro F, Nouvenne A, Thon JN, Italiano JE, Vitale M. Proplatelet generation in the mouse requires PKC epsilon-dependent RhoA inhibition. Blood. 2013 Aug;122(7):1305-11.   PMCID: No NIH funds
Gupta S, Wang LQ, Anderl J, Slifker MJ, Kirk C, Kruger WD. Correction of Cystathionine -Synthase Deficiency in Mice by Treatment with Proteasome Inhibitors. Human Mutation. 2013 Aug;34(8):1085-93.   PMCID: NIHMS 481408
Henry RA, Kuo YM, Andrews AJ. Differences in Specificity and Selectivity Between CBP and p300 Acetylation of Histone H3 and H3/H4. Biochemistry. 2013 Aug;52(34):5746-59.   PMCID: PMC 3756530
Jones R, Vuky J, Elliott T, Mead G, Arranz JA, Chester J, Chowdhury S, Dudek AZ, Muller-Mattheis V, Grimm MO, Gschwend JE, Wulfing C, Albers P, Li JG, Osmukhina A, Skolnik J, Hudes G. Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer. Investigational New Drugs. 2013 Aug;31(4):1001-7.   PMCID: No NIH funds
Kurimchak AH. Activation of p107 by fibroblast growth factor, which is essential for chondrocyte cell cycle exit, is mediated by the protein phosphatase 2A/B55alpha holoenzyme. Mol Cell Biol. 2013 Aug;33(16):3330-42.   PMCID: Pmc3753905
Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urologic Oncology-Seminars and Original Investigations. 2013 Aug;31(6):904-8.
Mitin T, Hunt D, Shipley WU, Kaufman DS, Uzzo R, Wu CL, Buyyounouski MK, Sandler H, Zietman AL. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial. Lancet Oncology. 2013 Aug;14(9):863-72.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications for the year 2013

Last updated on Tuesday, June 05, 2018